Ignite Creation Date:
2024-05-06 @ 6:06 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05549505
Status:
COMPLETED
Last Update Posted:
2024-05-07
First Post:
2022-09-07
Brief Title:
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Sponsor:
Arvinas Inc
Organization:
Arvinas Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| Vepdegestrant | View |
| Early breast cancer | View |
| Localized breast cancer | View |
| Untreated breast cancer | View |
| Pre-operative breast cancer | View |
| Treatment-naïve breast cancer | View |
| Neoadjuvant | View |
| Estrogen receptor | View |
| Estrogen receptor positive | View |
| ER | View |
| Hormone positive | View |
| Hormone receptor positive | View |
| HR | View |
| human epidermal growth factor receptor 2 | View |
| HER2- | View |
| ARV-471 | View |
| Anastrozole | View |
| Arimidex | View |
| Aromatase inhibitor | View |